Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Convoy Therapeutics is based upon the proprietary Skin-Penetrating And Cell Entering (SPACE) peptide technology.
James E. Carmichael: Chairman/Chief Financial Officer
Brandon French: Vice President
About the Company
Convoy Therapeutics, a subsidiary of ACTUS Biotechnologies, was founded in 2011 based upon the proprietary Skin-Penetrating And Cell Entering (SPACE) peptide technology developed by Professor Samir Mitragotri and his laboratory at University of California at Santa Barbara. The company is focused on enhancing the patient experience using its
proprietary platform technology and aggressively advancing this platform technology through the research and development process.
